Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway

• Main Authors: Lin Yang (Author), Chengda Zhang (Author), Jiaoting Chen (Author), Sheng Zhang (Author), Guixuan Pan (Author), Yanfei Xin (Author), Lin Lin (Author), Zhenqiang You (Author)
• Format: Book
• Published: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Context Shenmai Injection (SMI) is usually used to treat atherosclerotic coronary heart disease and viral myocarditis in China. However, the effect of SMI on multidrug resistance has not been reported. Objective To investigate the reversal effect of SMI in adriamycin (ADR) resistant breast cancer ce...